SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 17.96 |
| Enterprise Value ($M) | 20.53 |
| Book Value ($M) | -6.30 |
| Book Value / Share | -0.07 |
| Price / Book | -2.85 |
| NCAV ($M) | -6.30 |
| NCAV / Share | -0.07 |
| Price / NCAV | -2.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -14.27 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.09 |
| Current Ratio | 0.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.62 |
| Assets | 0.62 |
| Liabilities | 6.92 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| NVYTF – Novacyt S.A. | NWBO – Northwest Biotherapeutics, Inc. |
| NXEN – Nexien BioPharma, Inc. | OBSEF – ObsEva SA |
| ODTC – Odonate, Inc. |
Financial data and stock pages provided by
Fintel.io